Bio-FD&C Co

Bio-FD&C Co Receivables

The Accounts Receivable of Bio-FD&C Co (251120.KQ) as of Oct 22, 2026 is 1.98 B KRW. In the previous year, Accounts Receivable was 1.96 B KRW — a change of 1.28% (higher).

Receivables

1.98 BKRW

YoY

1.28%

Last updated:

Accounts Receivable of Bio-FD&C Co is 2024 1.98 B KRW. Accounts Receivable of Bio-FD&C Co was 2023 1.96 B KRW. It decreases by 1.28% higher compared to the previous year.

The Bio-FD&C Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
831.04 M KRW
Jan 1, 2019
864.68 M KRW
Jan 1, 2020
837.14 M KRW
Jan 1, 2021
2.02 B KRW
Jan 1, 2022
1.32 B KRW
Jan 1, 2023
1.96 B KRW
Jan 1, 2024
1.98 B KRW
The Bio-FD&C Co Receivables history
YEARReceivablesYoY
1.98 BKRW+1.28%
1.96 BKRW+48.26%
1.32 BKRW-34.74%
2.02 BKRW+141.47%
837.14 MKRW-3.19%
864.68 MKRW+4.05%
831.04 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Accounts Receivable of Bio-FD&C Co is 1.98 B KRW in 2024.

Accounts Receivable of Bio-FD&C Co changed from 1.96 B KRW to 1.98 B KRW, representing a 1.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Bio-FD&C Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bio-FD&C Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio-FD&C Co